| Wel-home Health Miles City | |
| 2300 Wilson St, Miles City, Montana 59301 | |
| (406) 874-5134 | |
| Name | Wel-home Health Miles City |
|---|---|
| Location | 2300 Wilson St, Miles City, Montana |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Home Health Aide |
| Medicare ID | 277079 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 59043, 59083, 59301, 59317, 59318, 59327, 59333, 59337, 59338, 59349, 59351 |
| NPI Number | 1528040904 |
| Organization Name | KISMET MILS, LLC |
| Doing Business As | WEL-HOME HEALTH MILES CITY |
| Address | 2300 Wilson St, Miles City, MT 59301 |
| Phone Number | 406-874-5134 |
News Archive
Braeburn Pharmaceuticals and Camurus announce that the first patient has been randomized in the double blind Phase 3 efficacy trial of CAM2038 in opioid-dependent patients. CAM2038 medications are designed for long-acting weekly and monthly administration.
Disparities in breast cancer mortality continued to be unacceptably high in Chicago and significantly larger than the national average according to new data released today at a rally sponsored by the Metropolitan Chicago Breast Cancer Task Force. The Task Force also announced results of the first year of data collection by the Chicago Breast Cancer Quality Consortium, which found many hospitals in Chicago are not meeting accepted quality standards.
Children watching commercials aired during televised sports events may frequently be exposed to violent and unsafe behavior, a study by a Penn State Children's Hospital physician suggests.
Seven out of ten U.S. children have low levels of vitamin D, raising their risk of bone and heart disease, according to a study by researchers at Albert Einstein College of Medicine of Yeshiva University. The striking findings suggest that vitamin D deficiency could place millions of children at risk for high blood pressure and other risk factors for heart disease.
Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced the completion of all planned surgeries in an ongoing Phase 2 clinical trial of the company's gene transfer approach to the treatment of advanced Parkinson's disease.
› Verified 7 days ago
| Quality Rating: |
News Archive
Braeburn Pharmaceuticals and Camurus announce that the first patient has been randomized in the double blind Phase 3 efficacy trial of CAM2038 in opioid-dependent patients. CAM2038 medications are designed for long-acting weekly and monthly administration.
Disparities in breast cancer mortality continued to be unacceptably high in Chicago and significantly larger than the national average according to new data released today at a rally sponsored by the Metropolitan Chicago Breast Cancer Task Force. The Task Force also announced results of the first year of data collection by the Chicago Breast Cancer Quality Consortium, which found many hospitals in Chicago are not meeting accepted quality standards.
Children watching commercials aired during televised sports events may frequently be exposed to violent and unsafe behavior, a study by a Penn State Children's Hospital physician suggests.
Seven out of ten U.S. children have low levels of vitamin D, raising their risk of bone and heart disease, according to a study by researchers at Albert Einstein College of Medicine of Yeshiva University. The striking findings suggest that vitamin D deficiency could place millions of children at risk for high blood pressure and other risk factors for heart disease.
Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced the completion of all planned surgeries in an ongoing Phase 2 clinical trial of the company's gene transfer approach to the treatment of advanced Parkinson's disease.
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 100 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 87.2 | 98.6 |
| How often the home health team checked patients’ risk of falling | 98.9 | 99.6 |
| How often the home health team checked patients for depression | 78.9 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 78 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 87.8 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 82.9 | 96.4 |
News Archive
Braeburn Pharmaceuticals and Camurus announce that the first patient has been randomized in the double blind Phase 3 efficacy trial of CAM2038 in opioid-dependent patients. CAM2038 medications are designed for long-acting weekly and monthly administration.
Disparities in breast cancer mortality continued to be unacceptably high in Chicago and significantly larger than the national average according to new data released today at a rally sponsored by the Metropolitan Chicago Breast Cancer Task Force. The Task Force also announced results of the first year of data collection by the Chicago Breast Cancer Quality Consortium, which found many hospitals in Chicago are not meeting accepted quality standards.
Children watching commercials aired during televised sports events may frequently be exposed to violent and unsafe behavior, a study by a Penn State Children's Hospital physician suggests.
Seven out of ten U.S. children have low levels of vitamin D, raising their risk of bone and heart disease, according to a study by researchers at Albert Einstein College of Medicine of Yeshiva University. The striking findings suggest that vitamin D deficiency could place millions of children at risk for high blood pressure and other risk factors for heart disease.
Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced the completion of all planned surgeries in an ongoing Phase 2 clinical trial of the company's gene transfer approach to the treatment of advanced Parkinson's disease.
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 59.9 | 79.6 |
| How often patients got better at getting in and out of bed | 76.4 | 81.1 |
| How often patients got better at bathing | 57.2 | 82.3 |
| How often patients’ breathing improved | 71.7 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 49.9 | 75 |
| How often home health patients had to be admitted to the hospital | 14.8 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 11.7 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 86.3 | 94 |
News Archive
Braeburn Pharmaceuticals and Camurus announce that the first patient has been randomized in the double blind Phase 3 efficacy trial of CAM2038 in opioid-dependent patients. CAM2038 medications are designed for long-acting weekly and monthly administration.
Disparities in breast cancer mortality continued to be unacceptably high in Chicago and significantly larger than the national average according to new data released today at a rally sponsored by the Metropolitan Chicago Breast Cancer Task Force. The Task Force also announced results of the first year of data collection by the Chicago Breast Cancer Quality Consortium, which found many hospitals in Chicago are not meeting accepted quality standards.
Children watching commercials aired during televised sports events may frequently be exposed to violent and unsafe behavior, a study by a Penn State Children's Hospital physician suggests.
Seven out of ten U.S. children have low levels of vitamin D, raising their risk of bone and heart disease, according to a study by researchers at Albert Einstein College of Medicine of Yeshiva University. The striking findings suggest that vitamin D deficiency could place millions of children at risk for high blood pressure and other risk factors for heart disease.
Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced the completion of all planned surgeries in an ongoing Phase 2 clinical trial of the company's gene transfer approach to the treatment of advanced Parkinson's disease.
› Verified 7 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | Not Available |
| Health team communicated well with them | Not Available |
| Health team discussed medicines, pain, and home safety | Not Available |
| How patients rated overall care from agency | Not Available |
News Archive
Braeburn Pharmaceuticals and Camurus announce that the first patient has been randomized in the double blind Phase 3 efficacy trial of CAM2038 in opioid-dependent patients. CAM2038 medications are designed for long-acting weekly and monthly administration.
Disparities in breast cancer mortality continued to be unacceptably high in Chicago and significantly larger than the national average according to new data released today at a rally sponsored by the Metropolitan Chicago Breast Cancer Task Force. The Task Force also announced results of the first year of data collection by the Chicago Breast Cancer Quality Consortium, which found many hospitals in Chicago are not meeting accepted quality standards.
Children watching commercials aired during televised sports events may frequently be exposed to violent and unsafe behavior, a study by a Penn State Children's Hospital physician suggests.
Seven out of ten U.S. children have low levels of vitamin D, raising their risk of bone and heart disease, according to a study by researchers at Albert Einstein College of Medicine of Yeshiva University. The striking findings suggest that vitamin D deficiency could place millions of children at risk for high blood pressure and other risk factors for heart disease.
Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced the completion of all planned surgeries in an ongoing Phase 2 clinical trial of the company's gene transfer approach to the treatment of advanced Parkinson's disease.
› Verified 7 days ago
The patient survey data of Wel-home Health Miles City is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 86 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 84 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 82 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 72 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 69 | 78 |
News Archive
Braeburn Pharmaceuticals and Camurus announce that the first patient has been randomized in the double blind Phase 3 efficacy trial of CAM2038 in opioid-dependent patients. CAM2038 medications are designed for long-acting weekly and monthly administration.
Disparities in breast cancer mortality continued to be unacceptably high in Chicago and significantly larger than the national average according to new data released today at a rally sponsored by the Metropolitan Chicago Breast Cancer Task Force. The Task Force also announced results of the first year of data collection by the Chicago Breast Cancer Quality Consortium, which found many hospitals in Chicago are not meeting accepted quality standards.
Children watching commercials aired during televised sports events may frequently be exposed to violent and unsafe behavior, a study by a Penn State Children's Hospital physician suggests.
Seven out of ten U.S. children have low levels of vitamin D, raising their risk of bone and heart disease, according to a study by researchers at Albert Einstein College of Medicine of Yeshiva University. The striking findings suggest that vitamin D deficiency could place millions of children at risk for high blood pressure and other risk factors for heart disease.
Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced the completion of all planned surgeries in an ongoing Phase 2 clinical trial of the company's gene transfer approach to the treatment of advanced Parkinson's disease.
› Verified 7 days ago
Wel-home Health Miles City Location: 2300 Wilson St, Miles City, Montana 59301 Ratings: Phone: (406) 874-5134 |